Clinical Trial Update: AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 [Phase 3]

View source ↗

Summary

Phase 3 trial comparing AZD0901 to investigator's choice of therapy in second- or later-line advanced or metastatic gastric or gastroesophageal junction adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• AZD0901

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 3 | Status: RECRUITING